心房の動: 概要
Darae Ko1,2,3, Mina K Chung4,5,6, Peter T Evans2
1Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School, Boston, Massachusetts.
JAMA
|December 16, 2024
まとめ
動脈動 (AF) は脳卒中と死亡リスクを高めます ライフスタイルの変化と 抗凝固剤は予防の鍵であり,キャテーテル切除は特定の患者にリズム制御を提供します.
科学分野:
- 心臓病科
- 電気生理学
背景:
- 動脈動 (AF) は1000万人以上の米国成人に影響し,脳卒中,心不全,死亡率のリスクを大幅に高めています.
- AFの検出は,臨床的遭遇,ウェアラブル,またはインプラントデバイスを通じて行われます. 断続的なAFは,インプラント可能なループレコーダーを使用して識別できます.
研究 の 目的:
- AF管理のための2023年ACC/AHA/ACCP/HRSガイドラインを概説する.
- AFの予防と合併症の軽減のためのライフスタイルの変更と抗凝固戦略を強調する.
- 特定のAF患者集団のカテーテル除去を含むリズム制御の選択肢を詳細に説明する.
主な方法:
- ガイドラインはAFの進化の4段階を提案しています リスクのある段階,AF前の段階,パロキシズム性/持続的なAF,そして永久的なAFです
- 脳卒中や血栓塞栓症のリスクの分層化は,抗凝固剤の決定に役立つ.
- 症状と心不全の患者のために,抗不律薬とカテーテル切除を含むリズム制御戦略の評価.
主要な成果:
- AFの全ての段階において,ライフスタイルの変更 (体重減少,運動) が推奨されます.
- 口服抗凝固剤 (ウォルファリンより直接投与する口服抗凝固剤) は,高リスク患者の脳卒中リスクを60~80%減らす.
- カテーテル切除は症状性心筋梗塞の第一線治療法であり,心筋梗塞の心筋梗塞の治療に推奨される.
結論:
- AFの管理にはリスクファクターの修正,抗凝固,早期のリズム制御を含む多面的なアプローチが必要です.
- ウォルファリンと比較して低血症のリスクがあるため,直接の経口抗凝固剤は脳卒中予防に好ましい.
- カテーテル切除は特定のAF患者群のアウトカムを改善し,生活の質と心血管の健康を改善します.
関連する概念動画
Disturbances in Heart Rhythm
898
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
898
Mitral Regurgitation I: Introduction
1
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1
Mechanism of Cardiac Arrhythmias
886
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
886
Mitral Valve Prolapse II: Assessment and Management
1
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1
Mitral Stenosis I: Introduction
1
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
775
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
775


